SOCS2 and hepatocellular carcinoma: Overexpression of METTL3 can increase the m6A modification of SOCS2 (suppressor of cytokine signaling 2) mRNA, reducing the stability of the downstream target SOCS2 mRNA and inhibiting the expression of SOCS2, thus promoting the proliferation and migration of HCC cells (25).